Aman Chauhan, Associate Professor at University of California, San Francisco shared a post on LinkedIn:
“Join me in Savannah for the latest advances in GI oncology at the MaTOS GI Summit.
I’ll be speaking about the evolving role of immunotherapy in neuroendocrine neoplasms. While immunotherapy has had limited success in well-differentiated NETs, there is growing optimism in poorly differentiated NEC, where emerging data are beginning to reshape treatment strategies.
Hope to see you there!”
Other articles featuring Aman Chauhan on OncoDaily.